Furthermore, NO2-FA treatment of immortalized fibroblasts from SAVI patients that had a gain-of-function mutation in STING dampened the STING-dependent IFN-I response. This evidence concerns the gene STING1 and STING-associated vasculopathy with onset in infancy.